middle.news
Zelira Therapeutics Advances HOPE® 1 FDA Trials with US$33M Fundraising
12:42pm on Wednesday 29th of April, 2026 AEST
•
Healthcare
Read Story
Zelira Therapeutics Advances HOPE® 1 FDA Trials with US$33M Fundraising
12:42pm on Wednesday 29th of April, 2026 AEST
Key Points
US$33M raised for HOPE® 1 SPV with Zelira holding 39.7%
Fundraising delayed but remains committed to closing
Q3 FY2026 net cash outflow of A$335k, cash at A$28k
Director loans of A$50,000 convertible at A$0.58
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Zelira Therapeutics (ASX:ZLD)
OPEN ARTICLE